Promethos Capital »

Dr. Reddy's Laboratories shares owned by Promethos Capital

Quarter-by-quarter ownership of Dr. Reddy's Laboratories (RDY) shares owned by Promethos Capital from 13F filings

Historical chart of Promethos Capital investment in Dr. Reddy's Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Dr. Reddy's Laboratories held by Promethos Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dr. Reddy's Laboratories by Promethos Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.6M 118k 73.35

More positions owned by Promethos Capital

Sap Se Equity (SAP)
Ubs Group Ag Reg Equity (UBS)
Novartis Equity (NVS)
Manulife Financial Corp Equity (MFC)
Icici Bank Equity (IBN)
Dr. Reddy S Laboratories Equity (RDY)
Canadian Natl Railway Equity (CNI)
Wipro Equity (WIT)
Shinhan Financial Group Equity (SHG)
Cgi Equity (GIB)
Nutrien Equity (NTR)
HSBC HLDGS Equity (HSBC)
Kb Financial Group Equity (KB)
Sk Telecom Equity (SKM)
Microsoft Corp Equity (MSFT)

View all positions for Promethos Capital

Top funds holding Dr. Reddy's Laboratories

BlackRock
Royal Bank of Canada
Robeco Institutional Asset Management B V
Goldman Sachs Group
Aikya Investment Management
Vanguard Group
Bank of America Corporation
Dimensional Fund Advisors
Morgan Stanley
Man Group
Lazard Asset Management
Grantham, Mayo, Van Otterloo & Co
Fisher Investments
Jpmorgan Chase & Co
Millennium Management

View all funds holding Dr. Reddy's Laboratories